Skip to content
DraconiticResearch
Search Sources API
197,768 studies31 sourcesUpdated 30 min ago
Peer-reviewedCC BYHealth affairs scholar

Hospital market concentration and hospital adoption of artificial intelligence and machine learning.

4 affiliations
  1. 1Department of Health Policy and Management, School of Public Health, University of Maryland at College Park, College Park, MD 20742, USA.
  2. 2Hospital And Public health interdisciPlinarY research (HAPPY) Lab, University of Maryland at College Park, College Park, MD 20742, USA.
  3. 3Center on Aging, University of Maryland at College Park, College Park, MD 20742, USA.
  4. 4Center for Seniors Uniting Nationwide to Support Health, INtegrated care, and Economics (SUNSHINE), University of Maryland at College Park, College Park, MD 20742, USA.

Abstract

We examined associations of hospital market concentration and organizational characteristics with artificial intelligence (AI) and machine learning (ML) use. We analyzed 2025 hospital survey data, measuring concentration with the Herfindahl-Hirschman index (HHI). Primary outcomes measured current use of AI/ML both integrated into and outside electronic health records (EHRs), and function counts requiring tools from both the EHR developer and another source. Alternative measures allowed either setting or source. Standard errors were clustered by hospital referral region. High vs low concentration was associated with a 6.7-percentage-point higher adjusted probability of generative-AI use in both settings (95% CI, 0.2-13.2), but not with any use (0.2; 95% CI, -4.9 to 5.2). Moderate concentration was associated with 0.20 fewer generative functions requiring both sources (95% CI, -0.39 to -0.01). System affiliation and accountable care organization (ACO) participation were positively associated with all 5 outcomes under both definitions. Market concentration was not consistently associated with AI/ML use across technologies and outcome definitions. System affiliation and ACO participation were consistently associated with greater use.

Related

  1. A Tale of Two Countries: Challenges in the Adoption of Artificial Intelligence in Medical Imaging in India and Singapore.
    Charlene Jin Yee Liew, Swati Goyal
    The Indian journal of radiology & imagingPeer-reviewedCC BY-NC-NDFull textEpidemiology & public healthEurope PMC
  2. Potential to improve early detection of lung cancer through expansion of focused and opportunistic screening approaches: a scoping review focusing on potential expansion of screening risk factors and adoption of artificial intelligence models.
    Tony S K Mok, Christian Finley, Deniz Köksal +4
    Lung cancer managementPeer-reviewedCC BY-NCFull textGeneral medicineEurope PMC
  3. Barriers and facilitators to healthcare artificial intelligence adoption in Wales: findings from focus groups
    Michal Pruski, Jasmine Rollings, Kathleen L. Withers
    Frontiers in digital healthPeer-reviewedCC BYFull textEpidemiology & public healthEurope PMCEurope PMCPMC
  4. Mapping the adoption and implementation of artificial intelligence (AI)-based conversational interface for tobacco cessation: a scoping review protocol.
    Navpreet Kaur, Priyobrat Rajkhowa, Shalini Bassi +4
    Systematic reviewsPeer-reviewedCC BYFull textPhysiologyEurope PMCDOAJ
  5. Baseline AI Economic Literacy and Enacted Adoption of Artificial Intelligence Tools by Oncology and Critical Care Professionals.
    Dragoș-Ciprian Negoiță, Ciprian Gindac, Akhil Akula +2
    Current oncology (Toronto, Ont.)Peer-reviewedCC BYFull textEpidemiology & public healthEurope PMC
BibTeX
@article{chen2026hospital,
  title = {{Hospital market concentration and hospital adoption of artificial intelligence and machine learning.}},
  author = {Jie Chen and Alice Yan},
  journal = {Health affairs scholar},
  year = {2026},
  month = oct,
  doi = {10.1093/haschl/qxag287},
  url = {https://europepmc.org/article/MED/42953653},
  note = {CC BY},
}
RIS
TY  - JOUR
TI  - Hospital market concentration and hospital adoption of artificial intelligence and machine learning.
AU  - Jie Chen
AU  - Alice Yan
PY  - 2026
DA  - 2026/10/16
JO  - Health affairs scholar
DO  - 10.1093/haschl/qxag287
UR  - https://europepmc.org/article/MED/42953653
AB  - We examined associations of hospital market concentration and organizational characteristics with artificial intelligence (AI) and machine learning (ML) use. We analyzed 2025 hospital survey data, measuring concentration with the Herfindahl-Hirschman index (HHI). Primary outcomes measured current use of AI/ML both integrated into and outside electronic health records (EHRs), and function counts requiring tools from both the EHR developer and another source. Alternative measures allowed either setting or source. Standard errors were clustered by hospital referral region. High vs low concentration was associated with a 6.7-percentage-point higher adjusted probability of generative-AI use in both settings (95% CI, 0.2-13.2), but not with any use (0.2; 95% CI, -4.9 to 5.2). Moderate concentration was associated with 0.20 fewer generative functions requiring both sources (95% CI, -0.39 to -0.01). System affiliation and accountable care organization (ACO) participation were positively associated with all 5 outcomes under both definitions. Market concentration was not consistently associated with AI/ML use across technologies and outcome definitions. System affiliation and ACO participation were consistently associated with greater use.
SN  - 2976-5390
ER  -